Synthesis, cytotoxicity, cell uptake and DNA interstrand cross-linking of 4,4′-dipyrazolylmethane-linked multinuclear platinum anti-cancer complexes

Anti-Cancer Drug Design

Volumn 16, Issue 2-3, 2001, Pages 91-98

  Wheate, Nial J ^a   Cullinane, Carleen ^a   Webster, Lorraine K ^a   Collins, J Grant ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cellular uptake; Cytotoxicity; Interstrand cross linking; Multinuclear platinum complexes

Indexed keywords

PLATINUM COMPLEX; PYRAZOLE; PYRAZOLE DERIVATIVE; TRANSPLATIN;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONCENTRATION RESPONSE; CYTOTOXICITY; DNA CROSS LINKING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL;

ANIMALS; CROSS-LINKING REAGENTS; DNA; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; ORGANOPLATINUM COMPOUNDS; PLASMIDS; PYRAZOLES; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE;

EID: 0035728568     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. 2 forms a unique macrochelate intrastrand crosslink with d(GpG)
2. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent
3. The synthesis and characterisation of dinuclear platinum complexes bridged by the 4,4′-dipyrazolylmethane ligand
4. Dinuclear complexes of platinum having anticancer properties. DNA-binding studies and biological activity of bis(4,4′-dipyrazolylmethane-N,N′)-bis[dichloroplatinum (II)] and related complexes
5. Cytotoxicity, cellular uptake and DNA binding of the novel trinuclear platinum BBR 3464 in sensitive and cisplatin resistant murine leukemia cells
6. Cytotoxicity and antitumor activity of bis(platinum) complexes. A novel class of platinum complexes active in cell lines resistant to both cisplatin and 1,2-diaminocyclohexane complexes
7. Comparison of chemical reactivity, cytotoxicity, interstrand cross-linking and DNA sequence specificity of bis(platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogues
8. Effects of geometric isomerism and ligand substitution in bifunctional dinuclear platinum complexes on binding properties and conformational changes in DNA
9. B → Z Conformational changes induced by a family of dinuclear bis(platinum) complexes
10. Tetranuclear platinum compound designed to overcome cisplatin resistance
11. Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies
12. Effects of quinoline as ligand in binding of mononuclear and dinuclear platinum complexes to DNA
13. Consequences of nucleic acid conformation on the binding of a trinuclear platinum drug
14. New antitumour-active azole-bridged dinuclear platinum(II) complexes: Synthesis, characterisation, crystal structures, and cytotoxic studies
15. Stimulation of cis-diamminedichloroplatinum(II) accumulation by modulation of passive permeability with genistein: An altered response in accumulation-defective resistant cells
16. Sequence-dependant conformational changes in DNA induced by polynuclear platinum complexes
17. A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system
18. The cellular basis of the efficiency of the trinuclear platinum BBR 3464 against cisplatin-resistant cells
19. Novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: Hypersensitivity of p53-mutant human tumour xenografts
20. Dinuclear platinum complexes form a novel intrastrand adduct with d(GpG), an anti-syn conformation of the macrochelate as observed by NMR and molecular modeling
21. Factors affecting formation and structure of DNA intrastrand cross-links by dinuclear platinum complexes
22. Synthesis, characterisation and cytotoxicity of trifunctional dinuclear platinum complexes: Comparison of effects of geometry and polyfunctionality on biological activity
23. Interaction of novel bis(platinum) complexes with DNA
24. Cellular pharmacology of polynuclear platinum anti-cancer agents
25. Comparison of cytotoxicity and cellular accumulation of polynuclear platinum complexes in L1210 murine leukemia cell lines
26. Assessment of toxicity of bis-platinum complexes in hypoxic and aerobic cells
27. Activity and DNA binding of new organoamidoplatinum (II) complexes
28. Characterization of acquired resistance to cis-diamminedichloroplatinum(II) in mouse leukemia cell lines
29. Synthesis, DNA binding and cytotoxicity of isohelical DNA groove binding platinum complexes
30. Thermal rearrangement of n-substituted pyrazoles to 4,4′-dipyrazolylmethane and 1,1,2(4,4′,4″-tripyrazolyl)-ethane
31. Current status of platinum-based antitumour drugs
32. A circular dichroism study of ethidium bromide binding to Z-DNA induced by dinuclear platinum complexes
33. A novel DNA structure induced by the anticancer bisplatinum compound cross-linked to a GpC site in DNA
34. Circumvention of platinum resistance: Structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 lines
35. DNA interactions of bifunctional dinuclear platinum(II) antitumor agents
36. + units bridged by 4,4′-dipyidyl selenides or sulfides
37. Comparison of the mode of action of a dinuclear platinum complex containing a pyridine derivative with its monomeric analog
38. Sequence specificity of DNA-DNA interstrand cross-link formation by cisplatin and dinuclear platinum complexes